Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Busulfan vs TBI Conditioning for T-ALL Allo-HSCT
NCT06673459Phase 3Not yet recruiting
- Sponsor
- First Affiliated Hospital of Soochow University
- Start
- Dec 2024
- Primary completion
- Nov 2029
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of busulfan in t-cell acute lymphoblastic leukemia (T-ALL), sponsored by First Affiliated Hospital of Soochow University. Planned start Dec 2024; status: not yet recruiting.
02
Drugs
busulfan
03
Conditions
t-cell acute lymphoblastic leukemia (T-ALL)
Beyond the preview
Go deeper on NCT06673459.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06673459.